The CIRROXABAN trial evaluates rivaroxaban's efficacy and safety in preventing complications of portal hypertension in cirrhotic patients, suggesting improved complication-free survival without significantly increasing major bleeding risk.

The CIRROXABAN trial evaluates rivaroxaban's efficacy and safety in preventing complications of portal hypertension in cirrhotic patients, suggesting improved complication-free survival without significantly increasing major bleeding risk.